Article Details
Retrieved on: 2022-12-11 12:18:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced interim results from the phase III HAVEN 7 study. · American Society of Hematology ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here